Common Stock, Shares, Outstanding of Cocrystal Pharma, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cocrystal Pharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Cocrystal Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 13,041,000, a 28% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Cocrystal Pharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 13,041,000 +2,867,000 +28% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 10,174,000 0 0% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 10,174,000 0 0% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 10,174,000 0 0% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 10,174,000 0 0% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 10,174,000 0 0% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 10,174,000 +2,030,668 +25% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 10,174,000 +2,031,000 +25% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 10,174,000 +2,031,000 +25% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 10,174,000 -87,295,000 -90% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 8,143,332 -89,325,668 -92% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 8,143,000 0 0% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 8,143,000 -89,325,755 -92% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 97,469,000 0 0% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 97,469,000 +26,000,000 +36% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 8,143,000 -62,296,000 -88% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 97,468,755 +28,904,755 +42% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 97,469,000 +45,328,000 +87% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 71,469,000 +19,328,000 +37% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 70,439,000 +35,289,000 +100% 31 Dec 2020 10-K 23 Mar 2022 2021 FY
Q3 2020 68,564,000 +36,943,000 +117% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 52,141,000 +20,520,000 +65% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 52,141,000 +20,521,000 +65% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 35,150,000 +5,212,000 +17% 31 Dec 2019 10-K 17 Mar 2021 2020 FY
Q3 2019 31,621,000 +1,698,000 +5.7% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 31,621,000 +1,698,000 +5.7% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 31,620,000 +7,218,000 +30% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 29,938,000 +5,663,000 +23% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 29,923,000 -698,316,000 -96% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 29,923,000 -696,609,000 -96% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 24,402,000 -689,629,000 -97% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 24,275,000 +474,000 +2% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 728,239,000 +14,207,492 +2% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 726,532,000 +22,276,593 +3.2% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 714,031,000 +713,326,745 +101288% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 23,801,000 -670,595,000 -97% 31 Dec 2016 10-K 21 Mar 2018 2017 FY
Q3 2016 714,031,508 +19,656,658 +2.8% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 704,255,407 +9,880,407 +1.4% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 704,255 -686,515,363 -100% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 694,396,000 +694,273,506 +566782% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 694,374,850 +694,252,356 +566764% 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 694,375,000 +694,253,115 +569597% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 687,219,618 +687,098,038 +565141% 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 122,494 +122,494 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 122,494 -69,988,606 -100% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 121,885 -69,339,440 -100% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 121,580 -63,021,389 -100% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 0 -63,142,969 -100% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 70,111,100 +6,968,131 +11% 30 Sep 2013 10-Q 18 Nov 2013 2013 Q3
Q2 2013 69,461,325 +7,488,356 +12% 30 Jun 2013 10-Q 15 Aug 2013 2013 Q2
Q1 2013 63,142,969 +6,206,804 +11% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 63,142,969 +7,961,804 +14% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 63,142,969 -4,400,341 -6.5% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 61,972,969 -5,056,427 -7.5% 30 Jun 2012 10-Q/A 28 Sep 2012 2012 Q2
Q1 2012 56,936,165 31 Mar 2012 10-Q/A 02 Oct 2012 2012 Q1
Q4 2011 55,181,165 +10,431,166 +23% 31 Dec 2011 10-K 01 Apr 2013 2012 FY
Q3 2011 67,543,310 30 Sep 2011 10-Q 21 Nov 2011 2011 Q3
Q2 2011 67,029,396 30 Jun 2011 10-Q/A 09 Sep 2011 2011 Q2
Q4 2010 44,749,999 31 Dec 2010 10-K 16 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.